Marcus Bantscheff

Active 2001–2025

87
Papers
23,841
Citations
63
h-index
80
i10-index

Citations

Citations per year for Marcus Bantscheff1983: 1 citations2000: 4 citations2002: 2 citations2003: 2 citations2004: 6 citations2005: 3 citations2006: 1 citations2007: 7 citations2008: 68 citations2009: 91 citations2010: 77 citations2011: 126 citations2012: 227 citations2013: 228 citations2014: 284 citations2015: 367 citations2016: 389 citations2017: 404 citations2018: 365 citations2019: 994 citations2020: 1,188 citations2021: 1,285 citations2022: 1,122 citations2023: 824 citations2024: 1,249 citations2025: 597 citations2026: 15 citations1984–1999: no citations, so these years are not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,381 citing papers, 26.7% of this breakdownChina: 1,756 citing papers, 13.9% of this breakdownGermany: 1,184 citing papers, 9.4% of this breakdownUnited Kingdom: 1,075 citing papers, 8.5% of this breakdownSwitzerland: 448 citing papers, 3.5% of this breakdownFrance: 383 citing papers, 3% of this breakdownCanada: 351 citing papers, 2.8% of this breakdownAustralia: 322 citing papers, 2.6% of this breakdownSweden: 282 citing papers, 2.2% of this breakdownItaly: 271 citing papers, 2.1% of this breakdownSpain: 261 citing papers, 2.1% of this breakdownNetherlands: 257 citing papers, 2% of this breakdown
0%26.7%Other 21.2%

Fields

  • Biochemistry, Genetics and Molecular Biology50.4%
  • Medicine19.8%
  • Chemistry13.2%
  • Immunology and Microbiology8.7%
  • Computer Science2.3%
  • Agricultural and Biological Sciences1.7%
  • Other3.9%

Topics

  • Protein Degradation and Inhibitors7.9%
  • Ubiquitin and proteasome pathways5.5%
  • Advanced Proteomics Techniques and Applications4.7%
  • Histone Deacetylase Inhibitors Research2.9%
  • Mass Spectrometry Techniques and Applications2.6%
  • Epigenetics and DNA Methylation2.6%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Catalytic in vivo protein knockdown by small-molecule PROTACs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2015 cited by 1,304

  2. Design of amidobenzimidazole STING receptor agonists with systemic activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Klein, Christopher B. Hopson, Jeffrey Guss, Marcus Bantscheff, Giovanna Bergamini, Michael Reilly, Yiqian Lian, Kevin J. Duffy, Jerry L. Adams, Kevin P. Foley, Peter J. Gough, Robert W. Marquis, James Smothers, Axel Hoos, John Bertin - Nature 2018 cited by 887

  3. Tracking cancer drugs in living cells by thermal profiling of the proteome

    Authors: , , , , , , , , , , , , , , , - Science 2014 cited by 1,233

  4. The emerging role of mass spectrometry-based proteomics in drug discovery

    Authors: , , , - Nature Reviews Drug Discovery 2022 cited by 347

  5. Mass-spectrometry-based draft of the human proteome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 1,907

  6. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

    Authors: , , , , , , , , , , , , - Nature Protocols 2015 cited by 708

  7. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , H. Christian Eberl, Amy Taylor, Thau Ho, Susan Merrihew, Shawn W. Foley, Anna Rutkowska, Mei Li, Stuart P. Romeril, Kristin Goldberg, Xing Zhang, Christopher S. Kershaw, Marcus Bantscheff, Anthony J. Jurewicz, Elisabeth A. Minthorn, Paola Grandi, Mehul Patel, Andrew B. Benowitz, Helai P. Mohammad, Aidan G. Gilmartin, Rab K. Prinjha, Donald Ogilvie, Christopher Carpenter, Dirk A. Heerding, Stephen B. Baylin, Peter A. Jones, Xiaodong Cheng, Bryan W. King, Juan I. Luengo, Allan M. Jordan, Ian D. Waddell, Ryan G. Kruger, Michael T. McCabe - Nature Cancer 2021 cited by 280

  8. Mass-spectrometry-based draft of the Arabidopsis proteome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claus Schwechheimer, Bernhard Küster - Nature 2020 cited by 539

  9. A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets

    Authors: , , , , - Molecular & Cellular Proteomics 2015 cited by 483

  10. Meltome atlas—thermal proteome stability across the tree of life

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Methods 2020 cited by 298

  11. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 1,532

  12. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Lindon, Gerard Drewes, Emmanuel H. Demont, Danette L. Daniels, Paola Grandi, Rab K. Prinjha, Mark A. Dawson - Science 2020 cited by 428

  13. Systematic analysis of protein turnover in primary cells

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 414

  14. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Wilson - Nature 2012 cited by 968

  15. Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Communications Biology 2020 cited by 221

  16. Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs

    Authors: , , , , , , , , , , , , , , , , , , - Angewandte Chemie International Edition 2021 cited by 116

  17. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition

    Authors: , , , , , , , , , , , , , - Nature Communications 2016 cited by 245

  18. Identifying drug targets in tissues and whole blood with thermal-shift profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2020 cited by 192

  19. Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP

    Authors: , , , , , , , - Nature Communications 2019 cited by 276

  20. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2021 cited by 203

  21. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2011 cited by 666

  22. Systematic discovery of biomolecular condensate-specific protein phosphorylation

    Authors: , , , , , , , , , - Nature Chemical Biology 2022 cited by 91

  23. Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat

    Authors: , , , , , , , , , , , , - Nature Chemical Biology 2016 cited by 257

  24. PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent Binding

    Authors: , , , , , , , , , , , - ACS Chemical Biology 2019 cited by 182